FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/04/065901 [Registered on: 18/04/2024] Trial Registered Prospectively
Last Modified On: 11/04/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Application of Ayurvedic medicine in the treatment of Vata Kaphaja Gridhrasi (Sciatica) 
Scientific Title of Study   Efficacy of Dashamoola kashaya with Eranda taila in Vata Kaphaja Gridhrasi with special reference to Sciatica- A Randomized controlled clinical trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Neethu K P 
Designation  PG Scholar 
Affiliation  KAHERs Shri BMK Ayurveda Mahavidyalaya Shahapur Belagavi 
Address  Department of Kayachikitsa KAHERs Shri BMK Ayurveda Mahavidyalaya Shahapur Belagavi

Belgaum
KARNATAKA
590003
India 
Phone  9497571949  
Fax    
Email  neethu.kp8@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Suhas Kumar Shetty 
Designation  Professor 
Affiliation  KAHERs Shri BMK Ayurveda Mahavidyalaya Shahapur Belagavi 
Address  Department of Kayachikitsa KAHERs Shri BMK Ayurveda Mahavidyalaya Shahapur Belagavi

Belgaum
KARNATAKA
590003
India 
Phone  9449603234  
Fax    
Email  drsuhasshetty@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Suhas Kumar Shetty 
Designation  Professor 
Affiliation  KAHERs Shri BMK Ayurveda Mahavidyalaya Shahapur Belagavi 
Address  Department of Kayachikitsa KAHERs Shri BMK Ayurveda Mahavidyalaya Shahapur Belagavi

Belgaum
KARNATAKA
590003
India 
Phone  9449603234  
Fax    
Email  drsuhasshetty@gmail.com  
 
Source of Monetary or Material Support  
KLE Shri BMK Ayurveda Hospital and Research centre Shahapur Belagavi  
 
Primary Sponsor  
Name  Dr Neethu K P 
Address  KAHERs Shri BMK Ayurveda Mahavidyalaya Shahapur Belagavi 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Neethu K P  KLE Shri BMK Ayurveda Hospital and Research centre Shahapur Belagavi  KLE Shri BMK Ayurveda Hospital and Research centre Shahapur Belagavi Dept of Kayachikitsa OPD no 6 OPD no 7
Belgaum
KARNATAKA 
9497571949

neethu.kp8@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee for Research on Human Subjects Shri BMK Ayurveda Mahavidyalaya and Hospital Shahapur Belagavi 590003  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M543||Sciatica. Ayurveda Condition: GRUDHRASI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Gandharvahasthadi Kashaya , Reference: Sahasrayogam 1/199, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 15(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -warm water), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Dashamoola Kashaya , Reference: Charaka sutra sthana 4/38, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 15(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -warm water), Additional Information: -
(2) Medicine Name: Eranda taila, Reference: Susrutha sutra sthana 45/114, Route: Oral, Dosage Form: Taila, Dose: 2.5(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -Dashamoola kashaya and Eranda taila given together with warm water. Reference-Cakradatta CikitsSangraha, Vatavyadhi Chikitsa, 22/58
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1 Subjects fulfilling the diagnostic criteria
irrespective of religion, sex, occupation, and
socio-economic status
2 Individuals aged between 20 years to 60 years
3 Unilateral or bilateral radiation of pain in the
sciatica nerve distribution 
 
ExclusionCriteria 
Details  1 History of spinal surgery and vertebral fracture
2 Diagnosed cases of Benign or malignant tumors of
the spine
3 Diagnosed cases of Tuberculosis of the Vertebral
column
4 Diagnosed Patients with major systematic
disorders like uncontrolled Diabetes mellitus
and Cardiovascular diseases
5 Patients having back pain due to non-spinal
illness will be excluded like Urinary tract
infection, Gastrointestinal diseases, and
uterine diseases
6 Pregnant and lactating women
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Primary outcomes will be based on Grading Vata-Kaphaja Gridhrasi Symptoms, VAS scale, Tenderness , Roland-Morris Disability Questionnaire,SF-36 QOL



 
0th day 15th day 30th day 
 
Secondary Outcome  
Outcome  TimePoints 
Secondary outcomes based on SLR test Walking speed time CRP and ESR  SLR test and Walking speed time (0th day 15th day 30th day) CRP and ESR (0th day and 30th day) 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   25/04/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Low back pain is an extremely common problem with a reported lifetime prevalence ranging from 49 percentage to 70 percentage An estimated 5 percentage to 10 percentage of patients with low back pain have sciatica The lifetime incidence of sciatica varies from 13 percentage to 40 percentage The corresponding annual incidence of an episode of sciatica ranges from 1 percentage to 5 percentage Sciatica is a debilitating condition resulting from sciatic nerve or nerve root pathology in which the patient experiences pain and or paresthesia in the sciatic nerve distribution or an associated lumbosacral nerve root A sedentary lifestyle stress improper posture heavy lifting continuous jerky movements long traveling are the potential risk factors In contemporary medicine palliative management NSAIDs and analgesics are the mainstays of pharmacotherapy but their long-term use has various adverse effects  As a last resort surgical procedures are carried out which are quite expensive with their limitations This painful disorder is equated with Gridhrasi in Ayurveda and  Ayurveda offers ample better options in the management of the same Today there is a need to find a drug to manage this condition that is cost effective easily available and has excellent results without hampering the daily routines of the patients In this disease mainly vyana vayu vitiation is observed but kapha is usually associated with dosha  So for the treatment of Gridhrasi the drug of choice should have vatashamaka kaphashamaka vatanulomaka dipana pachana and shulaprashamana properties Dashamoola and Eranda are the best choices having such properties to combat this condition Thus Dashamoola Kashaya with eranda taila is taken up for the study to see the effect on symptoms in Vata Kaphaja Gridhrasi

 
Close